PE  Sentinel Capital Partners

     Office Locations:

330 Madison Avenue, 27th Floor
New York, NY 10017
Phone: 212-688-3100
Fax: 212-688-6513



  • Middle Market



  • Business Services
  • Consumer Products & Services
  • Manufacturing & Industrial
  • Retail & Restaurant



    Sentinel Capital Partners is a private equity investment firm with approximately $2.6 billion of capital under management. Sentinel seeks to invest in businesses with attractive growth prospects and high quality management teams interested in becoming owners of the companies. The firm makes equity investments in a range of smaller, traditional middle-market private and public companies in the United States and Canada. Sentinel's preferred industry sectors are: Aerospace/Defense; Business Services; Consumer Products/Services; Distribution; Food/Restaurants; Franchising; Healthcare Products/Services; and Industrial Manufacturing. Sentinel prefers to invest between $20 million and $60 million, although the firm can invest up to $75 million of equity per transaction in companies in the business services/outsourcing, consumer products and services, food and restaurants, franchising, and manufacturing industries. The firm targets companies with at between $7 million and $35 million in EBITDA and enterprise values ranging from $40 million to $200 million.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    C. Scott Perry Partner
    David S. Lobel Founder and Managing Partner
    John C. Van Sickle Partner
    John F. McCormack Co-Founder and Senior Partner
    Joseph J. Catalano Managing Director & Director of Business Development


    Portfolio companies include:

      Chase Doors
        web link

        web link

      CIN Group
        web link

        web link

      Cottman Transmission Systems
        web link

      Critical Solutios International
        web link

        web link

      Engineered Controls
        web link

      Entre Computer Centers
        web link

      Floral Plant Growers
        web link

      Frame-n-Lens Optical
        web link

      Growing Family
        web link

      Huddle House
        web link

      Inscape Publishing
        web link

      Interim Healthcare Holdings

      LTI Flexible Products
        web link

        web link

      Massage Envy
        web link

      Met Merchandising Concepts
        web link

      Metro Dentalcare
        web link

      MidWest Wholesale Hardware
        web link

      National Spine & Pain Centers
        web link

      Nivel Holdings

      North American Rescue
        web link

      Office Depot
        web link

      Oregon Potato Company
        web link

      Precision Pipeline Solutions
        web link

      ReachOut Healthcare America
        web link

      Rocky Mountain Savings Bank
        web link

      Roma Restaurant Holdings

      Southern California Pizza Company

        web link

      Strategic Partners
        web link

      Trinity Consultants
        web link

        web link

      Vintage Holdings

      WellSpring Pharmaceutical
        web link


    Recent News: